Case–control study of second‐line therapies for type 2 diabetes in combination with metformin and the comparative risks of myocardial infarction and stroke

Publisher： John Wiley & Sons Inc

E-ISSN： 1463-1326|17|12|1194-1197

ISSN： 1462-8902

Source： DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol.17, Iss.12, 2015-12, pp. : 1194-1197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular risks associated with second‐line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study

By  

DIABETIC MEDICINE, Vol. 32, Iss. 11, 2015-11 ,pp. : 1460-1469

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second‐line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 2, 2018-02 ,pp. : 389-399

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of basal insulin therapies with regard to the risk of acute myocardial infarction in patients with type 2 diabetes: an observational cohort study

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 12, 2015-12 ,pp. : 1158-1165

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognosis following first acute myocardial infarction in Type 2 diabetes: a comparative population study

By  

DIABETIC MEDICINE, Vol. 19, Iss. 6, 2002-06 ,pp. : 448-455

John Wiley & Sons Inc

Access to resources Recommend Favorite

High‐molecular‐weight kininogen and the risk of a myocardial infarction and ischemic stroke in young women: the RATIO case–control study

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 10, Iss. 11, 2012-11 ,pp. : 2409-2412

John Wiley & Sons Inc

Access to resources Recommend Favorite